853072-54-5

Upstream product

• 355839-65-5 (-)-3-{[(2R,5S)-2,5-dihydro-5-(1-methylethyl)pyrazinyl]methyl}-6-methoxy-2-(triethylsilyl)-1H-indole 
• 355840-04-9 (-)-3-{[(2R,5S)-2,5-dihydro-5-(1-methylethyl)pyrazinyl]methyl}-6-methoxy-1-methyl-2-(triethylsilyl)-1H-indole 
• 355839-49-5 (2S,5R)-3,6-diethoxy-2-isopropyl-5-[3-(triethylsilyl)prop-2-ynyl]-2,5-dihydropyrazine 
• 185418-93-3 N_α-benzyl-6-methoxy-1-methyl-D-tryptophane ethyl ester 
• 185419-25-4 6-methoxy-N_a-methyl-D-tryptophan ethyl ester 
• 153898-63-6 2-iodo-5-methoxyaniline 
• 100-52-7 benzaldehyde 
• 474302-74-4 trans-(1S,3R)-(-)-2-benzyl-3-ethoxycarbonyl-7-methoxy-1-methoxycarbonylethyl-9-methyl-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole 

Downstream Products

• 474302-77-7 (-)-(6S,10S)-12-benzyl-5,6,7,8,10,11-hexahydro-3-methoxy-5-methyl-6,10-imino-9H-cyclooct[b]indol-9-one 

Relevant academic research and scientific papers

A general strategy for the synthesis of vincamajine-related indole alkaloids: Stereocontrolled total synthesis of (+)-dehydrovoachalotine, (-)-vincamajinine, and (-)-11-methoxy-17-epivincamajine as well as the related quebrachidine diol, vincamajine diol,

The highly convergent stereocontrolled total synthesis of (-)-vincamajinine (7), (-)-11-methoxy-17-epivincamajine (9), and the oxygen-bridged (+)-dehydrovoachalotine (22) are described. Key steps in the synthesis of 7 and 9 involved the stereospecific eno